Efficacy and Safety of BoozLiv™ as an add on therapy in patients with alcoholic liver disease: An open-label, randomized controlled trial

Background: Alcoholic Liver Disease (ALD) poses a significant global health threat, contributing to millions of deaths each year. Despite the well-established link between chronic alcohol consumption and liver damage, treatment options remain limited, emphasizing the need for innovative approaches....

Πλήρης περιγραφή

Λεπτομέρειες βιβλιογραφικής εγγραφής

Κύριοι συγγραφείς:	Mohammad Nezamuddin Khan, Balavigneshwaran A, Priyadharshini Ananthathandavan, Vijayakumar T M, Rajesh N A, Pavithra A, Sumitha A
Μορφή:	Artigo
Γλώσσα:	Inglês
Έκδοση:	KeAi Communications Co., Ltd. 2024-10-01
Σειρά:	Gastroenterology & Endoscopy
Θέματα:	BoozLiv™ erbal supplementation Alcoholic liver disease MELD Phyllantuhusniruri Hepatic parameters
Διαθέσιμο Online:	http://www.sciencedirect.com/science/article/pii/S2949752324000426
Ετικέτες:	Προσθήκη ετικέτας Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!